We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Concerned With Side Effect of Oscient Drug

Law360 (September 11, 2006, 12:00 AM EDT) -- Armed with studies showing a high risk of skin rashes from Oscient Pharmaceuticals Corp.’s Factive antibiotic, regulators at the FDA have planned a meeting on the safety and efficacy of the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.